A method for treating a human subject having breast cancer, said method comprising the following:

a)    Obtaining a nucleic acid sample from said human subject.
b)    Subjecting the sample to polymerase chain reaction and identifying the nucleotide present at position 101 of SEQ ID NO:1.
c)    Treating the human subject with “breast cancer treatment X” when a cytosine is detected at position 101 of SEQ ID NO:1.

Adapted from Kathleen Bragdon, “A Look at Personalized Medicine.”
 

Return to "Patent Eligibility for Personalized Medicine."